Human recombinant ACE2 reduces the progression of diabetic nephropathy.
about
Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cellsOral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunctionOral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionAdditive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus.Classical Renin-Angiotensin system in kidney physiologyPrevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.Nonclassical renin-angiotensin system and renal function.ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.Inflammation in the pathogenesis of microvascular complications in diabetes.ACE2 and diabetes: ACE of ACEs?Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibitionIdentification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injuryTargeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failureLoss of ACE2 exacerbates murine renal ischemia-reperfusion injury.Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.ACE and ACE2 in kidney diseaseNew perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.Angiotensin-converting enzyme 2: the first decade.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease TherapyDeletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.Rat Ace allele variation determines susceptibility to AngII-induced renal damageAngiotensin converting enzyme 2: a new important player in the regulation of glycemia.Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2Extracellular Superoxide Dismutase Protects against Proteinuric Kidney DiseaseDiminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity.Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy
P2860
Q27308039-66241EDD-A498-4F71-BC81-25F1A7F080A3Q28387627-883C3F2C-4953-446E-A097-82E2B24D90D8Q28538745-700C972A-3CBC-4F9A-8FFB-84FC9EEAFB21Q28569684-0B38FB82-798A-456B-AF46-A367B799F152Q30600509-1BB73EFD-2ACD-4521-A9FC-35B218AD8797Q33795353-67346BEB-FE3D-447E-ACAC-5D7B02C30CA9Q33800185-25C87743-7ACB-4172-B6FF-7EF080A4C206Q34065655-E6A54297-9B25-407B-B2B3-D635D7E97B2EQ34277437-83BF4FC2-08B4-4F60-B49D-777622827D1CQ34282114-B36128FA-1D14-4938-9D58-AD10FF0ABD59Q34293723-4C19BDF8-9A51-45EB-ADC6-9D682A76BACCQ34302600-10671DB4-AA86-43FD-8542-F0D17401B87FQ34319638-7673F389-2B9E-4D6F-A0E6-3E5C4AA9983FQ34355126-993CF6AD-06AF-499B-B265-3B6CB8742507Q34500735-0FEF4C9C-8DF6-4320-A7DE-E9BEAD010085Q34580630-B79C5405-18BD-4866-A94C-D37FBF319C42Q34784864-516938F9-03DE-437C-99E3-7FE2FF8789F7Q34866649-EDC010E8-7053-45BC-A2F5-F673CA94F82AQ34892110-EF331940-E560-4A85-A0BA-185612F32FC1Q34949521-B6D58108-8B0E-4707-A68B-EB8ECB142A74Q35050508-9EC8F92F-7B96-4D6D-8A58-F70A1BB8CF28Q35050821-2D503554-87FA-4EEC-B5C1-FF78786A9A42Q35137270-F0285914-68E5-4005-854A-ECC32A39FF76Q35152116-54C2A7C6-B853-4B32-A3E3-086A6997475EQ35192530-A1BED533-02C1-4857-AE59-0FD4A510C4CFQ35550937-F37AF43E-39E5-4731-945E-65EE0D9C2852Q35760437-B1D34608-8C1D-4F0A-A143-E3DF7834FCBFQ35923732-3F42D5A8-A475-473A-B024-30BFD5E73E7FQ35924552-AE300CA0-ABC6-4846-8D83-B0B9C39ACA18Q35974821-E5D67E2C-C055-4251-B05E-CBFE95AA54D6Q36020040-BA4AF64E-DC2F-4B40-9958-63BF3A7748D4Q36024889-29462E79-49B2-48AF-A379-351E0864B375Q36042210-F52118EB-BFB6-4E33-AA93-A6A261EF7BEBQ36087047-D0A629FA-2D85-4C74-BC6F-46B0F079C9A0Q36104801-57196B58-2FF2-4F95-B7F1-0FD08CC143BDQ36116045-F2BCC0F3-9670-42A5-B141-F90E89628BBCQ36392875-F7FFEBCF-0F61-4E5E-9BF8-B51FA789FA1FQ36473779-6E6DC5EB-31AA-4971-8789-0E1BFF94A450Q36477252-434EAE3D-6024-4FE8-AEEE-EF94AEF606CDQ36605186-1503CBE9-17BD-4BAF-9555-516D1B1CBD43
P2860
Human recombinant ACE2 reduces the progression of diabetic nephropathy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Human recombinant ACE2 reduces the progression of diabetic nephropathy.
@en
type
label
Human recombinant ACE2 reduces the progression of diabetic nephropathy.
@en
prefLabel
Human recombinant ACE2 reduces the progression of diabetic nephropathy.
@en
P2093
P2860
P356
P1433
P1476
Human recombinant ACE2 reduces the progression of diabetic nephropathy.
@en
P2093
Andrew M Herzenberg
Evelyne Janzek
Fung L Chow
Gavin Y Oudit
George C Liu
Hans Loibner
James W Scholey
Jiuchang Zhong
Joyce Zhou
Manfred Schuster
P2860
P304
P356
10.2337/DB09-1218
P407
P577
2009-11-23T00:00:00Z